Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 EUR | -1.63% | -3.97% | +0.41% |
22/04 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
11/04 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |
- Stock Market
- Equities
- ADMIN Stock
- News Administer Oyj